Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription 12.04.2021 9 Am J Cardiol 3 Am J Emerg Med 2 Am J Med 4 Angiology 1 Ann Thorac Surg 1 Arterioscler Thromb Vasc Biol 7 Atherosclerosis 1 Can J Cardiol 1 Cardiovasc Res 15 Catheter Cardiovasc Interv 1 Circ Cardiovasc Imaging 3 Circ Cardiovasc Qual Outcomes 1 Circ Genom Precis Med 2 Circ J 9 Circulation 10 Eur Heart J 1 Heart 4 Hypertension 2 Int J Cardiol Hypertens 14 J Am Coll Cardiol 4 J Cardiovasc Pharmacol 1 J Clin Endocrinol Metab 5 JAMA 2 Mayo Clin Proc 1 PLoS One 1 Psychosom Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. ABDELFATTAH OM, Saad AM, Aboshouk A, Hassanein M, et al
   Short-Term Outcomes of Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement in Kidney Transplant Recipients (From the US Nationwide Representative Study).
   Am J Cardiol. 2020 Dec 28. pii: S0002-9149(20)31398.
   PubMed         Abstract available
   
   
2. KUYAMA N, Hamatani Y, Okada A, Irie Y, et al
   Comparison of Clinical Characteristics, Natural History and Predictors of Disease Progression in Patients with Degenerative Mitral Stenosis versus Rheumatic Mitral Stenosis.
   Am J Cardiol. 2020 Dec 19. pii: S0002-9149(20)31354.
   PubMed         Abstract available
   
   
3. ULLAH W, Zahid S, Hamzeh I, Birnbaum Y, et al
   Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From a National Inpatient Sample Database).
   Am J Cardiol. 2020 Dec 21. pii: S0002-9149(20)31359.
   PubMed         Abstract available
   
   
4. HARHASH AA, Kennedy KF, Fendler TJ, Khumri TM, et al
   Comparison of Outcomes Among Patients With Cardiogenic Shock Admitted on Weekends Versus Weekdays.
   Am J Cardiol. 2021;144:20-25.
   PubMed         Abstract available
   
   
5. ELGENDY IY, Kolte D, Mansour MK, Sakhuja R, et al
   Incidence, Predictors, and Outcomes of Thrombotic Events in Hospitalized Patients With Viral Pneumonia.
   Am J Cardiol. 2021;143:164-165.
   PubMed        
   
   
6. ELBADAWI A, Elgendy IY, Albaeni A, Aly A, et al
   Trends and Outcomes of Transcatheter Valve Implantation in Patients With Prior Mediastinal Radiation.
   Am J Cardiol. 2021;143:167-168.
   PubMed        
   
   
7. JAIN V, Das S, Bhatia K, Aggarwal D, et al
   Utility of Exercise-Induced ST-Segment Elevation in Lead aVR for Detecting Left Main or Proximal Left Anterior Descending Disease.
   Am J Cardiol. 2021;144:150-151.
   PubMed        
   
   
8. SINNAEVE PR, Adriaenssens T
   Dual Antiplatelet Therapy De-escalation Strategies.
   Am J Cardiol. 2021;144 Suppl 1:S23-S31.
   PubMed         Abstract available
   
   
9. CERRATO E, Pavani M, Barbero U, Colombo F, et al
   Incidence, Management, Immediate and Long-Term Outcome of Guidewire and Device Related Grade III Coronary Perforations (from G3CAP - Cardiogroup VI Registry).
   Am J Cardiol. 2021;143:37-45.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

10. PRANATA R, Tondas AE, Huang I, Lim MA, et al
    Potential role of telemedicine in solving ST-segment elevation dilemmas in remote areas during the COVID-19 pandemic.
    Am J Emerg Med. 2021;42:242-243.
    PubMed        
    
    
11. MELE M, Tricarico L, Casavecchia G, Ieva R, et al
    Revascularization rates with coronary angioplasty and mortality in type 2 myocardial infarction: A meta-regression analysis.
    Am J Emerg Med. 2021;47:145-148.
    PubMed         Abstract available
    
    
12. MCLAREN JTT, Taher AK, Kapoor M, Yi SL, et al
    Sharing and Teaching Electrocardiograms to Minimize Infarction (STEMI): reducing diagnostic time for acute coronary occlusion in the emergency department.
    Am J Emerg Med. 2021;48:18-32.
    PubMed         Abstract available
    
    

    
    Am J Med

13. ETAHER A, Chew DP, Frost S, Saad YM, et al
    Prognostic implications of high sensitivity Troponin T levels among patients attending emergency departments and evaluated for an acute coronary syndrome.
    Am J Med. 2021 Apr 1. pii: S0002-9343(21)00162.
    PubMed         Abstract available
    
    
14. LEE MT, Mahtta D, Chen L, Hussain A, et al
    Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease.
    Am J Med. 2021 Apr 1. pii: S0002-9343(21)00213.
    PubMed         Abstract available
    
    

    
    Angiology

15. PAUL TK, Mukherjee D
    Is Colchicine Beneficial for the Prevention of Cardiovascular Events After Myocardial Infarction?
    Angiology. 2021 Apr 5:33197211007711. doi: 10.1177/00033197211007711.
    PubMed        
    
    
16. IMPRIALOS KP, Stavropoulos K, Doumas M, Athyros VG, et al
    The Impact of Ranolazine Treatment on Liver Tests in Patients With Coronary Artery Disease and Nonalcoholic Fatty Liver Disease.
    Angiology. 2021 Apr 8:33197211005597. doi: 10.1177/00033197211005597.
    PubMed        
    
    
17. ESENBOGA K, Kurtul A, Nazman H, Tekin CG, et al
    Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease.
    Angiology. 2021 Apr 7:33197211005590. doi: 10.1177/00033197211005590.
    PubMed         Abstract available
    
    
18. KELESOGLU S, Yilmaz Y, Elcik D, Cetinkaya Z, et al
    Systemic Immune Inflammation Index: A Novel Predictor of Contrast-Induced Nephropathy in Patients With Non-ST Segment Elevation Myocardial Infarction.
    Angiology. 2021 Apr 8:33197211007738. doi: 10.1177/00033197211007738.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

19. SANDNER SE, Schunkert H, Kastrati A, Milojevic M, et al
    Ticagrelor or aspirin after coronary artery bypass in patients with chronic kidney disease.
    Ann Thorac Surg. 2021 Apr 2. pii: S0003-4975(21)00590.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

20. JOHANSEN MO, Vedel-Krogh S, Nielsen SF, Afzal S, et al
    Per-Particle Triglyceride-Rich Lipoproteins Imply Higher Myocardial Infarction Risk Than Low-Density Lipoproteins: Copenhagen General Population Study.
    Arterioscler Thromb Vasc Biol. 2021 Apr 8:ATVBAHA120315639.
    PubMed         Abstract available
    
    

    
    Atherosclerosis

21. SENONER T, Plank F, Barbieri F, Beyer C, et al
    Added value of high-risk plaque criteria by coronary CTA for prediction of long-term outcomes.
    Atherosclerosis. 2020;300:26-33.
    PubMed         Abstract available
    
    
22. CHEN Q, Li Q, Li D, Chen X, et al
    Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
    Atherosclerosis. 2020;299:45-52.
    PubMed         Abstract available
    
    
23. KARJALAINEN MK, Holmes MV, Wang Q, Anufrieva O, et al
    Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study.
    Atherosclerosis. 2020;299:56-63.
    PubMed         Abstract available
    
    
24. GUARALDI G, Milic J, Prandini N, Ligabue G, et al
    (18)Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients.
    Atherosclerosis. 2020;297:127-135.
    PubMed         Abstract available
    
    
25. DE NISCO G, Hoogendoorn A, Chiastra C, Gallo D, et al
    The impact of helical flow on coronary atherosclerotic plaque development.
    Atherosclerosis. 2020;300:39-46.
    PubMed         Abstract available
    
    
26. LIM SS, Yang YL, Chen SC, Wu CH, et al
    Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Atherosclerosis. 2020;297:40-46.
    PubMed         Abstract available
    
    
27. THEN C, Then HL, Lechner A, Thorand B, et al
    Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
    Atherosclerosis. 2020;297:1-7.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

28. WELSH RC, Cantor WJ, Traboulsi M, Schampaert E, et al
    Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks: CJC Supplement - 40 Years of Innovation in Interventional Cardiology in Canada.
    Can J Cardiol. 2021 Apr 7. pii: S0828-282X(21)00173.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

29. YU J, Li J, Leaver PJ, Arnott C, et al
    Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS Program and CREDENCE trial.
    Cardiovasc Res. 2021 Apr 7. pii: 6214523. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

30. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    PubMed        
    
    
31. SACHEDINA AK, Ajluni SC, Jumean MF
    The use of a sentinel cerebral protection system during Impella CP removal in a patient with left ventricular thrombus.
    Catheter Cardiovasc Interv. 2020;96:504-506.
    PubMed         Abstract available
    
    
32. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    PubMed         Abstract available
    
    
33. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28742.
    PubMed         Abstract available
    
    
34. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    PubMed         Abstract available
    
    
35. MADIAS JE
    How common is comorbid takotsubo syndrome in patients with acute coronary syndromes?
    Catheter Cardiovasc Interv. 2020;96:725-726.
    PubMed        
    
    
36. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed         Abstract available
    
    
37. ARANZULLA TC
    One, two, three ... breakdance and twist.
    Catheter Cardiovasc Interv. 2020;96:601-608.
    PubMed         Abstract available
    
    
38. TOVAR FORERO MN, Van Mieghem NM, Daemen J
    Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
    Catheter Cardiovasc Interv. 2020;96:598-600.
    PubMed         Abstract available
    
    
39. ABU SHARAR H, Helfert S, Vafaie M, Pleger ST, et al
    Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Catheter Cardiovasc Interv. 2020;96:578-585.
    PubMed         Abstract available
    
    
40. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    PubMed         Abstract available
    
    
41. KANDZARI DE, Lembo NJ, Carlson HD, Kalynych A, et al
    Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study.
    Catheter Cardiovasc Interv. 2020;96:567-576.
    PubMed         Abstract available
    
    
42. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    PubMed         Abstract available
    
    
43. PARR CJ, Sharma R, Arora RC, Singal R, et al
    Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory.
    Catheter Cardiovasc Interv. 2020;96:547-555.
    PubMed         Abstract available
    
    
44. DE ROECK F, Tijskens M, Segers VFM
    Coronary-subclavian steal syndrome, an easily overlooked entity in interventional cardiology.
    Catheter Cardiovasc Interv. 2020;96:614-619.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

45. MEHTA A, Rigdon J, Tattersall MC, German CA, et al
    Association of Carotid Artery Plaque With Cardiovascular Events and Incident Coronary Artery Calcium in Individuals With Absent Coronary Calcification: The MESA.
    Circ Cardiovasc Imaging. 2021 Apr 8:CIRCIMAGING120011701.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

46. DEY P, Jarrin R, Mori M, Geirsson A, et al
    Leveraging Remote Physiologic Monitoring in the COVID-19 Pandemic to Improve Care After Cardiovascular Hospitalizations.
    Circ Cardiovasc Qual Outcomes. 2021 Apr 6:CIRCOUTCOMES120007618.
    PubMed        
    
    
47. SARAK B, Savu A, Kaul P, McAlister FA, et al
    Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome.
    Circ Cardiovasc Qual Outcomes. 2021 Apr 5:CIRCOUTCOMES120006646.
    PubMed         Abstract available
    
    
48. LI X, Gu D, Wang X, Diao X, et al
    Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018.
    Circ Cardiovasc Qual Outcomes. 2021 Apr 5:CIRCOUTCOMES120007025.
    PubMed         Abstract available
    
    

    
    Circ Genom Precis Med

49. RHAINDS D, Packard CJ, Brodeur MR, Niesor EJ, et al
    Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.
    Circ Genom Precis Med. 2021 Apr 2:CIRCGEN121003219.
    PubMed         Abstract available
    
    

    
    Circ J

50. BANDO YK
    Cancer and Coronary Heart Disease- To Bleed or Not to Bleed, That Is the Question.
    Circ J. 2021 Apr 8. doi: 10.1253/circj.CJ-21-0174.
    PubMed        
    
    
51. ARAI R, Murata N, Yamada A, Monden M, et al
    Pitfall of Isolated Right Ventricular Infarction Caused by Non-Dominant Right Coronary Artery.
    Circ J. 2021 Apr 7. doi: 10.1253/circj.CJ-21-0108.
    PubMed        
    
    

    
    Circulation

52. FERRARO R, Arbab-Zadeh A
    Letter by Ferraro and Arbab-Zadeh Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e805-e806.
    PubMed        
    
    
53. SAHOO S, Adamiak M, Mathiyalagan P, Kenneweg F, et al
    Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic.
    Circulation. 2021;143:1426-1449.
    PubMed         Abstract available
    
    
54. YACOUB M, Labib D
    Toward Meeting the Challenges of Improving Cardiovascular Health in Egypt.
    Circulation. 2021;143:1341-1342.
    PubMed        
    
    
55. LANSKY AJ, Kereiakes DJ, Baumbach A, Windecker S, et al
    Novel Supreme(TM) DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.052482.
    PubMed         Abstract available
    
    
56. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial.
    Circulation. 2021 Apr 7. doi: 10.1161/CIRCULATIONAHA.120.052766.
    PubMed         Abstract available
    
    
57. SHAH R
    Letter by Shah Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e807-e808.
    PubMed        
    
    
58. WENGER NK, Lewis SJ
    Incremental Change versus Disruptive Transformation: COVID-19 and the Cardiovascular Community.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.121.053860.
    PubMed        
    
    
59. BANGALORE S, Maron DJ, Stone GW, Hochman JS, et al
    Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e809-e810.
    PubMed        
    
    
60. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
    Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
    Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.
    PubMed        
    
    

    
    Eur Heart J

61. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    PubMed        
    
    
62. LANSKY A, Grubman D, Scheller B
    Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis.
    Eur Heart J. 2020;41:3729-3731.
    PubMed        
    
    
63. BALLANTYNE CM, Virani SS
    Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
    Eur Heart J. 2020;41:3910-3912.
    PubMed        
    
    
64. CANNON CP
    Chronic kidney disease: a high-risk group that deserves intensive lipid lowering.
    Eur Heart J. 2020;41:4124-4126.
    PubMed        
    
    
65. LIUZZO G, Pedicino D, Vinci R, Crea F, et al
    CD8 lymphocytes and plaque erosion: a new piece in the jigsaw.
    Eur Heart J. 2020;41:3561-3563.
    PubMed        
    
    
66. STOREY RF
    The long journey of individualizing antiplatelet therapy after acute coronary syndromes.
    Eur Heart J. 2020;41:3546-3548.
    PubMed        
    
    
67. KOTANIDIS CP, Antoniades C
    Selfies in cardiovascular medicine: welcome to a new era of medical diagnostics.
    Eur Heart J. 2020;41:4412-4414.
    PubMed        
    
    
68. TOKGOZOGLU L, Catapano AL
    Can EPA evaporate plaques?
    Eur Heart J. 2020;41:3933-3935.
    PubMed        
    
    
69. CREA F
    Guidelines on myocardial infarction, novel therapeutic targets in post-infarction remodelling, and a debate on the ISCHEMIA trial.
    Eur Heart J. 2021;42:1277-1280.
    PubMed        
    
    
70. BOHM M, Mahfoud F
    J-curve revisited.
    Eur Heart J. 2020;41:4283.
    PubMed        
    
    

    
    Heart

71. MCGOVERN L, Cosgrave J
    Axial flow ventricular assist devices in cardiogenic shock complicating acute myocardial infarction.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318226. doi: 10.1136/heartjnl-2020-318226.
    PubMed         Abstract available
    
    

    
    Hypertension

72. MEHLUM MH, Liestol K, Kjeldsen SE, Wyller TB, et al
    Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers.
    Hypertension. 2020;75:1584-1592.
    PubMed         Abstract available
    
    
73. RETHY LB, Feinstein MJ, Achenbach CJ, Townsend RR, et al
    Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension.
    Hypertension. 2021 Apr 5:HYPERTENSIONAHA12016263.
    PubMed         Abstract available
    
    
74. BRADY TM, Altemose K, Urbina EM
    Impact of the 2017 American Academy of Pediatrics' Clinical Practice Guideline on the Identification and Risk Stratification of Youth at Increased Cardiovascular Disease Risk.
    Hypertension. 2021 Apr 5:HYPERTENSIONAHA12114585.
    PubMed         Abstract available
    
    
75. MALIK R, Georgakis MK, Vujkovic M, Damrauer SM, et al
    Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses.
    Hypertension. 2021 Apr 5:HYPERTENSIONAHA12016534.
    PubMed         Abstract available
    
    

    
    Int J Cardiol Hypertens

76. VIJAYAN A, Chithra V, Sandhya C
    The relationship of lipid peroxidation and antioxidant status to selected modifiable risk factors in coronary artery disease patients.
    Int J Cardiol Hypertens. 2021;8:100077.
    PubMed         Abstract available
    
    
77. PUCCI G, Verdecchia P
    Chronological age and vascular age staring at each other on the ring of cardiovascular prevention.
    Int J Cardiol Hypertens. 2021;8:100076.
    PubMed        
    
    

    
    J Am Coll Cardiol

78. YAFASOVA A, Fosbol EL, Schou M, Baslund B, et al
    Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
    J Am Coll Cardiol. 2021;77:1717-1727.
    PubMed         Abstract available
    
    
79. SALLAM T
    Cardiovascular Outcomes in Systemic Lupus Erythematosus: Are We Dropping the Anchor or Dropping the Ball?
    J Am Coll Cardiol. 2021;77:1728-1730.
    PubMed        
    
    
80. TORII S, Sato Y, Otsuka F, Kolodgie FD, et al
    Eruptive Calcified Nodules as a Potential Mechanism of Acute Coronary Thrombosis and Sudden Death.
    J Am Coll Cardiol. 2021;77:1599-1611.
    PubMed         Abstract available
    
    
81. GARSHICK MS, Ward NL, Krueger JG, Berger JS, et al
    Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:1670-1680.
    PubMed         Abstract available
    
    
82. DIEKMANN J, Koenig T, Zwadlo C, Derlin T, et al
    Molecular Imaging Identifies Fibroblast Activation Beyond the Infarct Region After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:1835-1837.
    PubMed        
    
    
83. ITCHHAPORIA D
    ACC: Finding Our Strengths, Being Innovative, Unifying Our Global Cardiovascular Community.
    J Am Coll Cardiol. 2021 Apr 1. pii: S0735-1097(21)01008.
    PubMed        
    
    
84. DAVIS MB, Arendt K, Bello NA, Brown H, et al
    Team-Based Care of Women With Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 1/5.
    J Am Coll Cardiol. 2021;77:1763-1777.
    PubMed         Abstract available
    
    
85. LINDLEY KJ, Bairey Merz CN, Asgar AW, Bello NA, et al
    Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5.
    J Am Coll Cardiol. 2021;77:1778-1798.
    PubMed         Abstract available
    
    
86. LINDLEY KJ, Bairey Merz CN, Davis MB, Madden T, et al
    Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5.
    J Am Coll Cardiol. 2021;77:1823-1834.
    PubMed         Abstract available
    
    
87. BELLO NA, Bairey Merz CN, Brown H, Davis MB, et al
    Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5.
    J Am Coll Cardiol. 2021;77:1813-1822.
    PubMed         Abstract available
    
    
88. PARK K, Bairey Merz CN, Bello NA, Davis M, et al
    Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5.
    J Am Coll Cardiol. 2021;77:1799-1812.
    PubMed         Abstract available
    
    
89. CASTANER O, Ros E, Pinto X, Ortega E, et al
    Reply: Usefulness of Circulating Triglycerides and Estimated Remnant Cholesterol as Predictors of Cardiovascular Risk.
    J Am Coll Cardiol. 2021;77:1841-1843.
    PubMed        
    
    
90. LI J, Siegrist J
    Occupational Risks of Recurrent Coronary Heart Disease.
    J Am Coll Cardiol. 2021;77:1626-1628.
    PubMed        
    
    
91. HAMMOND-HALEY M, Hartley A, Essa M, DeLago AJ, et al
    Trends in Ischemic Heart Disease and Cerebrovascular Disease Mortality in Europe: An Observational Study 1990-2017.
    J Am Coll Cardiol. 2021;77:1697-1698.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

92. MCGINLEY C, Mordi IR, Kelly P, Currie P, et al
    Prehospital Administration of Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction Is Associated With Improved Long-Term Survival.
    J Cardiovasc Pharmacol. 2020;76:159-163.
    PubMed         Abstract available
    
    
93. TANNER R, Cronin M, Macken L, Murphy R, et al
    Real-World Experience With Antiplatelet Agents After Percutaneous Coronary Intervention in Patients With an Indication for an Oral Anticoagulant.
    J Cardiovasc Pharmacol. 2021;77:501-507.
    PubMed         Abstract available
    
    
94. LIN Y, Huang S, Chen Y, Wu Z, et al
    Helix B Surface Peptide Protects Cardiomyocytes From Hypoxia/Reoxygenation-induced Autophagy Through the PI3K/Akt Pathway.
    J Cardiovasc Pharmacol. 2020;76:181-188.
    PubMed         Abstract available
    
    
95. 
    Essential Role of the ELABELA-APJ Signaling Pathway in Cardiovascular System Development and Diseases: Erratum.
    J Cardiovasc Pharmacol. 2021;77:529.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

96. SHAO S, Zhou K, Liu X, Liu L, et al
    Predictive value of serum lipid for intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease.
    J Clin Endocrinol Metab. 2021 Apr 10. pii: 6219846. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    JAMA

97. WANG Y
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    PubMed        
    
    
98. OLSHANSKY B, Bhatt DL, Chung MK
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1332-1333.
    PubMed        
    
    
99. PARK KY, Park HK, Hwang HS
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1334.
    PubMed        
    
    
100. WELTY F, Bistrian B, Driscoll D
     Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
     JAMA. 2021;325:1333.
     PubMed        
     
     
101. NISSEN SE, Lincoff AM, Nicholls SJ
     Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk-Reply.
     JAMA. 2021;325:1334-1335.
     PubMed        
     
     

     
     Mayo Clin Proc

102. FERDINAND KC, Nedunchezhian S
     Physical Activity: Necessary, But Not Adequate Alone, to Overcome Disparities in Cardiovascular Disease in African Americans.
     Mayo Clin Proc. 2021;96:844-846.
     PubMed        
     
     
103. MEYER MR
     Chronic Coronary Syndromes in Women: Challenges in Diagnosis and Management.
     Mayo Clin Proc. 2021;96:1058-1070.
     PubMed         Abstract available
     
     

     
     PLoS One

104. EGGERS KM, Lindhagen L, Baron T, Erlinge D, et al
     Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry.
     PLoS One. 2021;16:e0249830.
     PubMed         Abstract available
     
     

     
     Psychosom Med

105. MOAZZAMI K, Wittbrodt MT, Lima BB, Levantsevych O, et al
     Neural Correlates of Stress and Abdominal Obesity in Patients With Coronary Artery Disease.
     Psychosom Med. 2020;82:272-280.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: